Search

Yarur, Andres J, Dermot McGovern, Maria T Abreu, Adam Cheifetz, Konstantinos Papamichail, Parakkal Deepak, Alexandra Bruss, et al. 2023. “Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2908-2917.e10.

Gold, Stephanie L, Loren G Rabinowitz, Laura Manning, Laurie Keefer, William Rivera-Carrero, Stephanie Stanley, Alexis Sherman, et al. 2023. “High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.”. Inflammatory Bowel Diseases 29 (3): 423-29.

Seika, Philippa, Jocelyn Chang, Su Min Hong, Sarah Ballou, Vikram Rangan, Chethan Ramprasad, Johanna Iturrino, et al. 2025. “Glucagon-Like Peptide-1 Receptor Agonists Are Associated With a Lower Risk of Peptic Ulcer Disease: A Nationwide Cohort Study.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association.

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Treatment Optimization of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease.”. Expert Review of Gastroenterology & Hepatology.

Salwen-Deremer, Jessica K, Sarah Ballou, Megan Petrik, Miguel Regueiro, Corey A Siegel, Laurie Keefer, and GastroPsych Business Plan Working Group. 2025. “A Practical Guide to Incorporating a Psychologist into a Gastroenterology Practice.”. Gastroenterology.

Cassavaugh, Jessica, Maria Serena Longhi, and Simon C Robson. 2025. “Impact of Estrogen on Purinergic Signaling in Microvascular Disease.”. International Journal of Molecular Sciences 26 (5).

Owings, Anna H, Sarah C Glover, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Delays in Utilizing Biological Therapy Is a Global Reality and May Lead to Negative Outcomes in Patients With Inflammatory Bowel Disease.”. Digestive Diseases and Sciences 70 (3): 1248-49.

Abou-Donia, Mohamed B, Lisa A Conboy, Efi Kokkotou, Eric Jacobson, Eman M Elmasry, Passent Elkafrawy, Megan Neely, Cameron R Dale Bass, and Kimberly Sullivan. 2025. “Retraction Notice to ‘Screening for Novel Central Nervous System Biomarkers in Veterans With Gulf War Illness’ [Neurotoxicology and Teratology 61 (2017) 36-46].”. Neurotoxicology and Teratology 107: 107423.

Papamichael, Konstantinos, and Adam S Cheifetz. 2025. “Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?”. Alimentary Pharmacology & Therapeutics 61 (2): 369-70.

Burdine, Lauren K, Shana Rakowsky, Laurie Grossberg, Loren Rabinowitz, BIDMC IBD Research Center, Adam S Cheifetz, and Sarah Ballou. 2024. “Irritable Bowel Syndrome/Inflammatory Bowel Disease Overlap: Less Common Than We Think.”. Gastro Hep Advances 3 (8): 1135-37.